Up-to-date information on this veterinary medicinal product is available on the [Veterinary Medicines Information website](https://medicines.health.europa.eu/veterinary/select-language?destination=/node/210934 "(opens in a new window)")
Therapeutic Indication
N/A
Therapeutic Area (MeSH)
N/AATC Code
N/A
ATC Item
N/A
Pharmacotherapeutic Group
Immunologicals for felidae
Active Substance (Summary)
N/AINN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| attenuated feline rhinotracheitis herpesvirus (FHV F2 strain) | N/A | attenuated feline rhinotracheitis herpesvirus (fhv f 2 strain) |
| inactivated feline calicivirosis antigens (FCV 431 and G1 strains) | N/A | inactivated feline calicivirosis antigens (fcv 431 and g 1 strains) |
| attenuated feline panleucopenia virus (PLI IV) | N/A | attenuated feline panleucopenia virus (pli iv) |
| FeLV recombinant canarypox virus (vCP97) | N/A | felv recombinant canarypox virus (vcp 97) |
| attenuated Chlamydophila felis (905 strain) | N/A | attenuated chlamydophila felis (905 strain) |
EMA Name
Purevax RCPCh FeLV
Medicine Name
Purevax RCPCh FeLV
Aliases
N/ANo risk management plan link.
